Universal screening of all pregnant women for Group B streptococcal infection has been recommended
in the United States of America because of high neonatal infection rates (1.7 to 4 per 1000) and
vaginal carriage rates (15 to 40%). Such screening may not be necessary in Antigua and Barbuda with
a neonatal infection rate of 0.4/1000 and vaginal carriage rate of 2–9%.